Related Experiment Videos
Glycopeptide antibiotic resistance.
Jeff Pootoolal1, John Neu, Gerard D Wright
1Antimicrobial Research Centre, Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada. pootoojc@mcmail.cis.mcmaster.ca
Annual Review of Pharmacology and Toxicology
|January 25, 2002
Summary
Glycopeptide resistance is a growing threat due to evolving bacterial mechanisms. Innovative strategies are crucial to develop new antibiotics and combat resistance in staphylococci and enterococci.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Glycopeptide antibiotics are critical in combating bacterial infections.
- The emergence of resistance mechanisms poses a significant threat to their efficacy.
- Resistance has been observed in key pathogens like enterococci, staphylococci, and streptococci.
Purpose of the Study:
- To highlight the escalating challenge of glycopeptide resistance in bacteria.
- To underscore the need for novel approaches to overcome existing and emerging resistance.
- To discuss the complexities involved in developing new glycopeptide-based therapies.
Main Methods:
- Analysis of emerging resistance mechanisms in bacterial pathogens.
- Review of current antibiotic arsenal and its limitations.
- Assessment of challenges in developing new antimicrobial agents.
Main Results:
- Resistance has largely emerged through altered cell wall biosynthesis pathways.
- New resistance and tolerance mechanisms are appearing in virulent staphylococci and streptococci.
- The chemical complexity and diverse resistance types complicate the development of new solutions.
Conclusions:
- Overcoming glycopeptide resistance requires innovative strategies.
- Development of new antibiotics or inhibitors of resistance elements is essential.
- Addressing glycopeptide resistance is a complex, multifaceted challenge.